<PAGE>

================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-K/A
                                (AMENDMENT NO. 1)

                       FOR ANNUAL AND TRANSITIONAL REPORTS
                       PURSUANT TO SECTIONS 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934
                   FOR THE FISCAL YEAR ENDED DECEMBER 31, 2001

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

                         COMMISSION FILE NUMBER 0-19635
                               GENTA INCORPORATED
   (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CERTIFICATE OF INCORPORATION)

            DELAWARE                                         33-0326866
 (STATE OR OTHER JURISDICTION OF                            (IRS EMPLOYER
  INCORPORATION OR ORGANIZATION)                         IDENTIFICATION NUMBER)

          TWO CONNELL DRIVE
     BERKELEY HEIGHTS, NEW JERSEY                              07922
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)                     (ZIP CODE)

                                 (908) 286-9800
              (REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
        SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: NONE

           SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:

                          COMMON STOCK, $.001 PAR VALUE

                                (TITLE OF CLASS)

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.  Yes [X]  No [ ]

    Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]

    The approximate aggregate market value of the voting common equity held by
non-affiliates of the registrant was $403,346,448 as of March 8, 2002. For
purposes of determining this number, 25,209,153 shares of common stock held by
affiliates are excluded. For purposes of making this calculation, the registrant
defined affiliates as including all directors, executive officers and beneficial
owners of more than ten percent of the common stock of the Company.

    As of March 8, 2002, the registrant had 66,565,781 shares of Common Stock
outstanding.

                       DOCUMENTS INCORPORATED BY REFERENCE

                                      None.


<PAGE>


                                Introductory Note


    This Form 10-K/A is being filed by Genta Incorporated ("Genta" or the
"Company") to (i) amend and restate in its entirety the Consolidated Statements
of Stockholders' Equity contained in Item 8 of Part II of the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2001 filed with the
Securities and Exchange Commission on April 1, 2002 (the "Original 10-K") and
(ii) to make certain miscellaneous corrections to the description of Exhibits
10.76 and 10.77 on the Exhibit list contained in Item 14(c) of Part IV of the
Original 10-K. The change to the Consolidated Statements of Stockholders' Equity
is being made solely to correct two incorrect column headings.


                                       2
<PAGE>



                               GENTA INCORPORATED
                 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
              FOR THE YEARS ENDED DECEMBER 31, 1999, 2000 AND 2001

<TABLE>
<CAPTION>


                          Convertible                                                                    Accumulated
                        Preferred Stock   Common Stock   Additional               Accrued                   Other          Total
                        ---------------  --------------    Paid-in  Accumulated  Dividends   Deferred   Comprehensive  Stockholders'
(In thousands)          Shares  Amount   Shares  Amount   Capital     Deficit     Payable  Compensation Income (Loss)     Equity
                        ------  -------  ------  ------  ---------- -----------  --------- ------------ -------------  -------------
<S>                      <C>     <C>     <C>      <C>     <C>        <C>         <C>         <C>             <C>          <C>
BALANCE AT
 JANUARY 1, 1999........  633    $ --    10,426   $11     $131,260   $(132,054)  $  4,476    $    (733)      $ --         $  2,960

Comprehensive loss:
 Net loss...............   --      --        --    --           --      (7,444)        --           --         --           (7,444)
                                                                                                                          --------
 Total comprehensive
  loss..................                                                                                                    (7,444)

Issuance of common
  stock upon conversion                                             .
  of convertible
  preferred stock....... (233)     --     8,918     9        1,634          --     (1,643)          --         --               --
Issuance of common
  stock in connection
  with a private
  placement, net of
  issuance costs of
  $1,071,756............   --      --     3,810     4       10,353          --         --           --         --           10,357
Issuance of common stock
  in connection with
  exercise of warrants
  and stock options.....   --      --       293    --        1,392          --         --           --         --            1,392
Preferred stock
  dividends.............   --      --     2,010     2       (2,435)         --      2,301           --         --             (132)
Deferred compensation
  related to stock
  options...............   --      --        --    --        4,659          --         --       (1,585)        --            3,074
                         ----     ---    ------   ---     --------   ---------   --------    ---------        ---         --------
BALANCE AT DECEMBER 31,
  1999..................  400      --    25,457    26      146,863    (139,498)     5,134       (2,318)        --           10,207

Comprehensive loss:
  Net loss..............   --      --       --     --           --     (12,451)        --           --         --          (12,451)
  Unrealized investment
    gain................   --      --       --     --           --          --         --           --         95               95
                                                                                                                          --------
  Total comprehensive
    loss................                                                                                                   (12,356)

Issuance of common
  stock upon conversion
  of convertible
  preferred stock....... (139)     --   14,486     15          (14)         --         --           --         --                1
Issuance of common
  stock in connection
  with two private
  placements, net of
  issuance costs of
  $2,548,116............   --      --    6,458      6       40,095          --         --           --         --           40,101
Issuance of common
  stock in connection
  with exercise of
  warrants and stock
  options...............   --      --    3,345      3        3,254          --         --           --         --            3,257
Preferred stock
  dividends.............   --      --      953      1        5,133          --     (5,134)          --         --               --
Deferred compensation
  related to stock
  options...............   --      --       --     --        7,368          --         --        1,237         --            8,605
Issuance of common
  stock in connection
  with rights to Relgen
  license agreement.....   --      --       10     --           84          --         --           --         --               84
</TABLE>
                                       3
<PAGE>


                               GENTA INCORPORATED
                 CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
              FOR THE YEARS ENDED DECEMBER 31, 1999, 2000 AND 2001

<TABLE>
<CAPTION>

                          Convertible                                                                    Accumulated
                        Preferred Stock   Common Stock   Additional               Accrued                   Other          Total
                        ---------------  --------------    Paid-in  Accumulated  Dividends   Deferred   Comprehensive  Stockholders'
(In thousands)          Shares  Amount   Shares  Amount   Capital     Deficit     Payable  Compensation Income (Loss)     Equity
                        ------  -------  ------  ------  ---------- -----------  --------- ------------ -------------  -------------
<S>                      <C>      <C>   <C>       <C>     <C>        <C>           <C>       <C>            <C>          <C>
Issuance of common
  stock in connection
  with MBI asset
  purchase..............   --      --      376     --        2,400          --       --           --           --           2,400
Value of shares to be
  issued related to
  license agreement.....   --      --       --     --        1,268          --       --           --           --           1,268
BALANCE AT DECEMBER 31,
  2000..................  261      --   51,085     51      206,451    (151,949)      --       (1,081)          95          53,567
                         ----     ---   ------    ---     --------   ---------     ----      -------        -----        --------

Comprehensive loss:
  Net loss..............   --      --       --     --           --     (46,713)      --           --           --         (46,713)
  Unrealized investment
   loss.................   --      --       --     --           --          --       --           --         (161)           (161)
                                                                                                                         --------
  Total comprehensive
   loss.................                                                                                                  (46,874)

Issuance of common
  stock upon conversion
  of convertible
  preferred stock.......   --      --        2     --           --          --       --           --           --              --
Issuance of common stock
  in connection with
  private placement,
  net of issuance
  costs of $502,212.....   --      --    2,500      3       32,220          --       --           --           --          32,223
Issuance of common stock
  in connection with
  exercise of warrants
  and stock options.....   --      --   12,245     12        8,309          --       --           --           --           8,321
Issuance of common stock
  as hiring bonus.......   --      --        6     --           --          --       --           --           --              --
Issuance of common stock
  related to license
  agreement.............   --      --      162     --           --          --       --           --           --              --
Deferred compensation
  related to stock
  options...............   --      --       --     --        1,705          --       --         (632)          --           1,073
                         ----     ---   ------    ---     --------   ---------     ----      -------        -----        --------
BALANCE AT DECEMBER 31,
   2001................. $261     $--   66,000    $66     $248,685   $(198,662)    $ --      $(1,713)       $ (66)       $ 48,310
                         ====     ===   ======    ===     ========   =========     ====      =======        =====        ========

</TABLE>

                                       4
<PAGE>




EXHIBIT NO.       DESCRIPTION OF DOCUMENT
-----------       -----------------------

10.76(16)         Agreement of Lease, the Connell Company, dated June 28, 2000.

10.77(16)         Agreement of Sublease, Expanets, Inc., dated August 13, 2001.



                                       5
<PAGE>


                                   SIGNATURES

    Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, as amended, the Registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized, on this
2nd day of April 2002.

                                        Genta Incorporated

                                        /s/  Raymond P. Warrell, Jr., M.D.
                                        ----------------------------------------
                                        Raymond P. Warrell, Jr., M.D.
                                        Chairman, President, Chief Executive
                                        Officer and Principal Executive Officer


    Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, this report has been signed below by the following persons on behalf of
the registrant and in the capacities and on the dates indicated.

<TABLE>
<CAPTION>

                    SIGNATURE                            CAPACITY                          DATE
                    ---------                            --------                          ----
<S>                                        <C>                                         <C>
/s/ Raymond P. Warrell, Jr., M.D.          Chairman, President, Chief Executive        April 2, 2002
---------------------------------          Officer and Principal Executive Officer
Raymond P. Warrell, Jr., M.D.

/s/ Alfred J. Fernandez                    Principal Financial and Accounting          April 2, 2002
---------------------------------          Officer and Executive Vice President
Alfred J. Fernandez

/s/ Betsy McCaughey, Ph.D.                 Director                                    April 2, 2002
---------------------------------
Betsy McCaughey, Ph.D.

/s/ Daniel D. Von Hoff, M.D.               Director                                    April 2, 2002
---------------------------------
Daniel D. Von Hoff, M.D.

/s/ Harlan J. Wakoff                       Director                                    April 2, 2002
---------------------------------
Harlan J. Wakoff

/s/ Michael S. Weiss                       Director                                    April 2, 2002
---------------------------------
Michael S. Weiss

/s/ Patrick Zenner                         Director                                    April 2, 2002
---------------------------------
Patrick Zenner

</Table>
                                       6